Abandon du tabagisme et effets neuropsychiatriques indésirables: Les médecins de famille sont-ils coincés entre l'arbre et l'écorce?
En mai 2010, à la suite de signalements d'effets indésirables neuropsychiatriques, Santé
Canada a obligé les fabricants du plus récent médicament d'ordonnance pour l'abandon du …
Canada a obligé les fabricants du plus récent médicament d'ordonnance pour l'abandon du …
Smoking cessation and neuropsychiatric adverse events: Are family physicians caught between a rock and a hard place?
In May 2010, following reports of neuropsychiatric adverse events, Health Canada
compelled the makers of the newest smoking cessation prescription medication, varenicline …
compelled the makers of the newest smoking cessation prescription medication, varenicline …
[PDF][PDF] Smoking cessation and neuropsychiatric adverse events: Are physicians between a rock and a hard place?
In May 2010, following reports of neuropsychiatric adverse events, Health Canada
compelled the makers of the newest smoking cessation prescription medication, varenicline …
compelled the makers of the newest smoking cessation prescription medication, varenicline …
neuropsychiatric considerations
C ELS - Disease Interrupted, tobacco reduction ans cessation, 2014 - books.google.com
Canada compelled the makers of varenicline to carry a boxed warning label. A year prior, in
the US, similar boxed warnings were introduced for both varenicline and bupropion. These …
the US, similar boxed warnings were introduced for both varenicline and bupropion. These …
Smoking Cessation Drugs Pose Little Neuropsychiatric Risk
A Slomski - JAMA, 2016 - jamanetwork.com
The smoking cessation medications varenicline and bupropion do not increase the risk of
moderate-to-severe neuropsychiatric adverse events, including among smokers with stable …
moderate-to-severe neuropsychiatric adverse events, including among smokers with stable …
[HTML][HTML] Patient understanding of the neuropsychiatric risks associated with branded bupropion hydrochloride products used for smoking cessation
J Ascher, A Stemhagen, M Stender, B Win… - Drugs-Real World …, 2018 - Springer
Abstract Background Bupropion hydrochloride (Zyban) is an effective aid to smoking
cessation; however, its use has previously been associated with neuropsychiatric adverse …
cessation; however, its use has previously been associated with neuropsychiatric adverse …
[BOOK][B] Les aides pharmacologiques à l'arrêt tabagique
A Royer - 2010 - policycommons.net
" Dans les milieux de soins psychiatriques, la dépendance tabagique des clients est
rarement abordée et peu de personnes souffrant de problèmes de santé mentale se font …
rarement abordée et peu de personnes souffrant de problèmes de santé mentale se font …
Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States
D Shah, A Shah, X Tan, U Sambamoorthi - Drug and alcohol dependence, 2017 - Elsevier
Background In 2009, the FDA required a black box warning (BBW) on bupropion and
varenicline, the two commonly prescribed smoking cessation agents due to reports of …
varenicline, the two commonly prescribed smoking cessation agents due to reports of …
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind …
RM Anthenelli, NL Benowitz, R West, L St Aubin… - The Lancet, 2016 - thelancet.com
Background Substantial concerns have been raised about the neuropsychiatric safety of the
smoking cessation medications varenicline and bupropion. Their efficacy relative to nicotine …
smoking cessation medications varenicline and bupropion. Their efficacy relative to nicotine …
Comparative safety of smoking cessation pharmacotherapies during a government-sponsored reimbursement program
G Carney, M Maclure, S Malfair… - Nicotine and …, 2021 - academic.oup.com
Abstract Introduction The British Columbia Ministry of Health launched a Smoking Cessation
Program on September 30, 2011, providing financial coverage for smoking cessation …
Program on September 30, 2011, providing financial coverage for smoking cessation …